Cutting-edge drug shows promise for patients with NRAS-driven melanoma

A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a pathway-targeted therapy could be an effective treatment for certain melanoma patients and fill an unmet clinical need for patients with advanced disease.

Raccontata damedicalxpress.com